Evaxion Biotech A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
1.490
+0.100 (7.19%)
Nov 22, 2024, 4:00 PM EST - Market closed
Evaxion Biotech Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Net Income | - | -22.13 | -23.17 | -24.53 | -15.02 | -11.2 | Upgrade
|
| Depreciation & Amortization | - | 0.62 | 0.57 | 0.34 | 0.11 | 0.08 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 0.09 | - | - | - | Upgrade
|
| Stock-Based Compensation | - | 0.48 | 0.94 | 1.38 | 3.41 | 2.36 | Upgrade
|
| Other Operating Activities | - | 1.78 | -1.33 | -0.36 | -1.15 | 1.16 | Upgrade
|
| Change in Accounts Receivable | - | 1.11 | -1.49 | 1.86 | -2.5 | -0.34 | Upgrade
|
| Change in Accounts Payable | - | 0.5 | -0.6 | -0.65 | 1.8 | 0.51 | Upgrade
|
| Change in Other Net Operating Assets | - | -0.05 | -0.79 | 0.02 | 0.92 | 0.4 | Upgrade
|
| Operating Cash Flow | - | -17.69 | -25.77 | -21.93 | -12.44 | -7.02 | Upgrade
|
| Capital Expenditures | - | -0.09 | -0.29 | -1.3 | -0.15 | -0.06 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | -0.06 | -0.04 | - | Upgrade
|
| Other Investing Activities | - | -0.01 | 0.02 | 0.03 | -0.21 | -0.01 | Upgrade
|
| Investing Cash Flow | - | -0.09 | -0.27 | -1.33 | -0.39 | -0.07 | Upgrade
|
| Long-Term Debt Issued | - | 0.07 | 7.85 | - | - | 0.15 | Upgrade
|
| Long-Term Debt Repaid | - | -0.7 | -0.42 | -0.29 | -0.07 | -0.07 | Upgrade
|
| Net Debt Issued (Repaid) | - | -0.63 | 7.43 | -0.29 | -0.07 | 0.08 | Upgrade
|
| Issuance of Common Stock | - | 9.17 | 0.43 | 53.85 | 9.02 | 9.44 | Upgrade
|
| Other Financing Activities | - | 2.16 | - | -3.76 | -0.13 | -0.01 | Upgrade
|
| Financing Cash Flow | - | 10.69 | 7.85 | 49.81 | 8.82 | 9.51 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | -0.51 | -0.79 | -0.21 | 0.29 | -0.3 | Upgrade
|
| Net Cash Flow | - | -7.6 | -18.98 | 26.33 | -3.73 | 2.13 | Upgrade
|
| Free Cash Flow | - | -17.78 | -26.07 | -23.23 | -12.59 | -7.08 | Upgrade
|
| Free Cash Flow Margin | - | -24353.42% | - | - | - | - | Upgrade
|
| Free Cash Flow Per Share | - | -6.50 | -11.03 | -11.92 | -8.15 | -5.10 | Upgrade
|
| Cash Interest Paid | - | 0.07 | 0.17 | 0.03 | 0.03 | 0.04 | Upgrade
|
| Cash Income Tax Paid | - | -1.6 | -0.75 | -0.85 | -0.81 | -0.69 | Upgrade
|
| Levered Free Cash Flow | - | -9.12 | -16.89 | -14.33 | -7.54 | -3.97 | Upgrade
|
| Unlevered Free Cash Flow | - | -8.56 | -16.39 | -14.23 | -7.52 | -3.95 | Upgrade
|
| Change in Net Working Capital | - | -4.31 | 1.82 | -1.55 | 0.5 | -0.46 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.